Treatment of Fabry disease in patients and patients without ERT-therapy

摘要

A dosing plan is provided to treat the patient's Fabry disease. Some methods relate to the treatment of patients with or without ERT-therapy experience. Some methods include administering about 123 mg free base equivalent of megalastat to the patient to improve left ventricular mass and / or to improve cell-cell glycosphingolipids.